Developer docs
API playgroundTry for free, no card

Search company profiles

World Diabetes Foundation

Full company profile

uuid02lmvx2

Namestring
World Diabetes Foundation
Legal namestring
World Diabetes Foundation
Company typeenum
Private
Founded yearint
2002
Descriptiontext

World Diabetes Foundation (WDF) is a charitable foundation founded in 2002 and headquartered in Gentofte, Denmark, that funds diabetes prevention and care projects in low- and middle-income countries. Rather than selling products, WDF operates as a grant-maker and convener: it disburses funds to local implementing partners, runs the Global Diabetes Walk awareness campaign (active 20+ years), and has built two newer programmatic pillars — the Diabetes Compass digital health platform and the Diabetes Investment Accelerator (DIA), an innovative-financing mechanism that extends WDF beyond traditional grant-making into blended-finance structures. Capacity-building is delivered through the Partner2Partner Academy, and active partnerships span WHO, the International Diabetes Federation, KHPT (India), UMID Charity Union (Uzbekistan), Last Mile Care (Africa), and the Indigenous Diabetes Outcomes Fund, giving the foundation geographic reach across Europe, Africa, Asia, and Latin America.

WDF's revenue mechanics rely on donations, annual fundraising campaigns, and an endowment. Governance is shaped by significant representation from pharmaceutical and life-sciences incumbents: multiple board members hold roles at Novo Nordisk, and the LEO Foundation also holds a board seat. This implies both operational influence and a likely concentration of donor underwriting within a narrow set of institutional givers, even as the project portfolio itself is geographically diversified across 30+ countries. The disclosed executive team is small (four named leaders), and recent moves — including a 2025 Uzbekistan fundraiser with UMID, a 2026 Bengaluru fundraiser with KHPT under the 'Beyond Clinics' banner, and onboarding of a former WHO NCD Director to the board — point to a steady rather than transformative expansion pace.

From an investor lens, WDF is best understood as a mission-anchored philanthropic platform with quasi-institutional reach. Its competitive position rests on long-tenured partnerships, brand credibility, and alignment with WHO and UN SDG frameworks rather than on proprietary technology or AI capability, neither of which is evidenced in available data. The DIA initiative is the most commercially adjacent product and is the likeliest vector for any future fee-based or co-financed revenue models.

Short descriptiontext

The World Diabetes Foundation is a Danish charitable foundation that funds diabetes prevention and care projects in low- and middle-income countries through grants, digital platforms, and innovative financing mechanisms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBagsværd, Denmark
HQ citystring
Bagsværd
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diabetes prevention programs, global health funding, non-communicable disease grants, low-income country health, diabetes care initiatives
Industry4 codes
1Public Health Financing, Budgeting & Grants Management
CodeHLAJAMACPrimaryYes
2International Grantmaking & Development Foundations
CodeBPAGAKAHPrimaryNo
3Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryNo
4Disease-Specific Global Programs (HIV/TB/Malaria/NTDs)
CodeHLAJAKAFPrimaryNo
NAICS code3 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
SIC code1 code
  • Services-Membership Organizations8600
Product category
Global Health Foundation / Nonprofit Diabetes Funding
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Donations and Fundraising
TypeGrants Donations
Description

WDF raises funds through donations and dedicated fundraising campaigns. Donors support specific diabetes prevention and care projects directly through the Foundation's fundraising programme.

worlddiabetesfoundation.org
2Foundation Endowment
TypeOthers
Description

WDF operates with an endowment separate from the fundraising programme, providing sustainable funding for operations and grants.

worlddiabetesfoundation.org
3Grants to Partners
TypeOthers
Description

WDF provides grants to implementing partners in low- and middle-income countries for diabetes prevention, care, and advocacy projects.

worlddiabetesfoundation.org
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Diabetes Compass
Description

Digital support platform offering digital support to healthcare professionals and people with diabetes to improve health outcomes in low- and middle-income countries.

worlddiabetesfoundation.org
+3 more records
Core offering1 text field

World Diabetes Foundation (WDF) is an independent Danish charitable foundation that funds and supports projects for the prevention and care of diabetes and related non-communicable diseases (NCDs) in low- and middle-income countries. The Foundation provides grants to implementing partners such as NGOs, healthcare systems, and government bodies, and operates supporting platforms including the Diabetes Compass digital tool, the Diabetes Investment Accelerator (DIA), the Global Diabetes Walk awareness campaign, and the Partner2Partner Academy for capacity building.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Contributing to SDG 3.4: reduce by one-third premature mortality from NCDs through prevention and treatment
+1 more record
Product overview1 text field

World Diabetes Foundation operates as a grant-giving foundation rather than a traditional product company. Its offerings consist of funding programs and initiatives focused on diabetes prevention and care in low- and middle-income countries. The main offerings include the Global Diabetes Walk (awareness campaign), Diabetes Compass (digital health support platform), the Diabetes Investment Accelerator (innovative financing mechanism), Partner2Partner Academy (capacity building platform), and various fundraising programs. The foundation's work is organized around three intervention areas: Access to Care, Primary Prevention, and Advocacy.

Product and service5 records
1Global Diabetes Walk
CategoryAwareness Campaign Program
Description

Annual global awareness campaign running for over 20 years, promoting physical, mental, and social well-being for people at risk of or living with diabetes through community walking events.

2Diabetes Compass
CategoryDigital Health Platform
Description

Digital support platform providing resources to healthcare professionals and people with diabetes to improve health outcomes in low- and middle-income countries.

3Diabetes Investment Accelerator (DIA)
CategoryInnovative Financing Program
Description

Program that explores, implements, and scales innovative financing mechanisms to address the growing burden of diabetes and related NCDs in low- and middle-income countries, including portfolio companies such as Last Mile Care and the Indigenous Diabetes Outcomes Fund.

4Partner2Partner Academy
CategoryCapacity Building Platform
Description

Capacity-building platform fostering collaboration, learning, and innovation among WDF partners through south-to-south knowledge sharing, networking, and clinical and organisational capacity building for diabetes prevention and care.

5WDF Fundraising Programme
CategoryDonor / Fundraising Programme
Description

Donor programme enabling individuals and organizations to fund specific diabetes prevention and care projects, including pilot projects and later phases of successful completed projects, via the Foundation's official donation platform.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-01-01
Description

KHPT leads WDF's 2026 fundraiser 'Beyond Clinics' in Bengaluru, India. The 18-month project aims to improve diabetes and hypertension prevention and care for marginalized adults in urban and peri-urban communities, working with the Greater Bengaluru Authority and Department of Health.

2UMID Сharity Union of Persons with Disabilities and People with Diabetes Mellitus in Uzbekistan
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-01-01
Description

UMID Charity union is implementing WDF's 2025 fundraiser project 'Improving diabetes control and quality of life for children in Uzbekistan'. The project runs from January 2025 to March 2026, targeting children with type 1 diabetes in rural areas through summer health camps, school staff training, and parent support groups.

worlddiabetesfoundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health start-up in WDF's Diabetes Investment Accelerator portfolio committed to transforming healthcare access for industrial workers in India through one-stop-shop physical and digital centers near workplaces.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Initiative supported by WDF's Diabetes Investment Accelerator to establish an Indigenous-led outcomes financing model for type 2 diabetes prevention and management in Canadian Indigenous communities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WDF works with WHO on NCD prevention and control, including UN High-Level Meetings on NCDs and the Global Diabetes Compact. Dr Bente Mikkelsen, a former WHO Director for NCDs, serves on WDF's Board.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WDF leverages IDF's KIDS modules 'Children and Diabetes at School' for training programs. Dr Kaushik Ramaiya, WDF board member, serves as Vice President of IDF.

7Ministry of Health of the Republic of Uzbekistan
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government partner for the 2025 fundraiser project on type 1 diabetes in children, collaborating on healthcare system improvements.

worlddiabetesfoundation.org
8Greater Bengaluru Authority
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Government partner for the 2026 'Beyond Clinics' fundraiser, working on community-based diabetes and hypertension care for marginalized urban populations.

worlddiabetesfoundation.org
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large philanthropic foundation funding child health, NCDs, and climate. Comparable as a LMIC-focused grantmaker with NCD portfolio and outcomes-based financing expertise overlapping with WDF's Diabetes Investment Accelerator.

TypeBroad incumbent
Description

Major philanthropic vehicle funding global health initiatives including NCD prevention and public health data. Comparable in deploying large-scale resources against NCDs and population health, particularly through advocacy and policy channels.

TypeBroad incumbent
Description

Major US-based philanthropic foundation with a significant diabetes program and global health investments. Comparable as a large-scale grantmaker addressing diabetes in low-resource settings, though with broader geographic and disease focus.

TypeEmerging player
Description

Global health organization focused on cardiovascular disease and NCD prevention in LMICs, with strong WHO alignment. Comparable as an NCD-focused funder/implementer, particularly given WHO policy linkages similar to WDF.

TypeBroad incumbent
Description

Large Danish philanthropic foundation with a major focus on diabetes, NCDs, and global health. Highly comparable given overlapping Danish origins, shared board members with WDF, and parallel mission in diabetes prevention and care in LMICs.

TypeDirect peer
Description

Global health organization implementing health system strengthening and access programs in LMICs. Comparable operational model — partnership-driven, country-led implementation focused on expanding access to care for NCDs and other conditions.

TypeBroad incumbent
Description

Large UK-based global health foundation funding NCD research, infectious disease, and health system strengthening in LMICs. Comparable grantmaking scale and mission alignment with SDG 3.4 priorities.

TypeBroad incumbent
Description

Largest global health foundation, increasingly active in NCDs alongside its core infectious disease portfolio. Comparable in scale, LMIC focus, and convening power; sets the funding benchmark for diabetes/NCD advocacy organizations.

TypeDirect peer
Description

Global health nonprofit working across NCDs, digital health, and health system strengthening in LMICs. Highly comparable as a mission-driven organization operating diabetes/NCD programs and digital health platforms in similar geographies.

TypeDirect peer
Description

Umbrella global diabetes organization with overlapping leadership and KIDS module adoption by WDF. Direct peer in mission and constituency, though IDF operates as a federation of member associations rather than a grantmaker.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

World Diabetes Foundation

Global Health Foundation / Nonprofit Diabetes Fundingworlddiabetesfoundation.org

The World Diabetes Foundation is a Danish charitable foundation that funds diabetes prevention and care projects in low- and middle-income countries through grants, digital platforms, and innovative financing mechanisms.

What World Diabetes Foundation does

World Diabetes Foundation (WDF) is a charitable foundation founded in 2002 and headquartered in Gentofte, Denmark, that funds diabetes prevention and care projects in low- and middle-income countries. Rather than selling products, WDF operates as a grant-maker and convener: it disburses funds to local implementing partners, runs the Global Diabetes Walk awareness campaign (active 20+ years), and has built two newer programmatic pillars — the Diabetes Compass digital health platform and the Diabetes Investment Accelerator (DIA), an innovative-financing mechanism that extends WDF beyond traditional grant-making into blended-finance structures. Capacity-building is delivered through the Partner2Partner Academy, and active partnerships span WHO, the International Diabetes Federation, KHPT (India), UMID Charity Union (Uzbekistan), Last Mile Care (Africa), and the Indigenous Diabetes Outcomes Fund, giving the foundation geographic reach across Europe, Africa, Asia, and Latin America.

WDF's revenue mechanics rely on donations, annual fundraising campaigns, and an endowment. Governance is shaped by significant representation from pharmaceutical and life-sciences incumbents: multiple board members hold roles at Novo Nordisk, and the LEO Foundation also holds a board seat. This implies both operational influence and a likely concentration of donor underwriting within a narrow set of institutional givers, even as the project portfolio itself is geographically diversified across 30+ countries. The disclosed executive team is small (four named leaders), and recent moves — including a 2025 Uzbekistan fundraiser with UMID, a 2026 Bengaluru fundraiser with KHPT under the 'Beyond Clinics' banner, and onboarding of a former WHO NCD Director to the board — point to a steady rather than transformative expansion pace.

From an investor lens, WDF is best understood as a mission-anchored philanthropic platform with quasi-institutional reach. Its competitive position rests on long-tenured partnerships, brand credibility, and alignment with WHO and UN SDG frameworks rather than on proprietary technology or AI capability, neither of which is evidenced in available data. The DIA initiative is the most commercially adjacent product and is the likeliest vector for any future fee-based or co-financed revenue models.

World Diabetes Foundation firmographics

Firmographics
Name
World Diabetes Foundation
Legal name
World Diabetes Foundation
Website
https://worlddiabetesfoundation.org
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Short description
The World Diabetes Foundation is a Danish charitable foundation that funds diabetes prevention and care projects in low- and middle-income countries through grants, digital platforms, and innovative financing mechanisms.
Ownership category
akta.pro rank

World Diabetes Foundation industry classification

Industry
Product category
Global Health Foundation / Nonprofit Diabetes Funding
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Public Health Financing, Budgeting & Grants Management (HLAJAMAC)
akta.pro secondary industries
International Grantmaking & Development Foundations (BPAGAKAH), Health & Medical Research Grantmaking Foundations (BPAGAKAL), Disease-Specific Global Programs (HIV/TB/Malaria/NTDs) (HLAJAKAF)

Keywords

  • Diabetes prevention programs
  • Global health funding
  • Non-communicable disease grants
  • Low-income country health
  • Diabetes care initiatives

Where World Diabetes Foundation is headquartered

Location

Headquarters

HQ city
Bagsværd
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

World Diabetes Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Donations and Fundraising: WDF raises funds through donations and dedicated fundraising campaigns. Donors support specific diabetes prevention and care projects directly through the Foundation's fundraising programme.
  2. Foundation Endowment: WDF operates with an endowment separate from the fundraising programme, providing sustainable funding for operations and grants.
  3. Grants to Partners: WDF provides grants to implementing partners in low- and middle-income countries for diabetes prevention, care, and advocacy projects.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels8 records

World Diabetes Foundation product offering

Product offering

Core offering

World Diabetes Foundation (WDF) is an independent Danish charitable foundation that funds and supports projects for the prevention and care of diabetes and related non-communicable diseases (NCDs) in low- and middle-income countries. The Foundation provides grants to implementing partners such as NGOs, healthcare systems, and government bodies, and operates supporting platforms including the Diabetes Compass digital tool, the Diabetes Investment Accelerator (DIA), the Global Diabetes Walk awareness campaign, and the Partner2Partner Academy for capacity building.

Product overview

World Diabetes Foundation operates as a grant-giving foundation rather than a traditional product company. Its offerings consist of funding programs and initiatives focused on diabetes prevention and care in low- and middle-income countries. The main offerings include the Global Diabetes Walk (awareness campaign), Diabetes Compass (digital health support platform), the Diabetes Investment Accelerator (innovative financing mechanism), Partner2Partner Academy (capacity building platform), and various fundraising programs. The foundation's work is organized around three intervention areas: Access to Care, Primary Prevention, and Advocacy.

Differentiator

Problem solved

Functional benefit

Brands

  • Diabetes Compass: Digital support platform offering digital support to healthcare professionals and people with diabetes to improve health outcomes in low- and middle-income countries.
  • Diabetes Investment Accelerator (DIA)
  • Partner2Partner Academy
  • Global Diabetes Walk

Products and services

  • Global Diabetes Walk Annual global awareness campaign running for over 20 years, promoting physical, mental, and social well-being for people at risk of or living with diabetes through community walking events.
  • Diabetes Compass Digital support platform providing resources to healthcare professionals and people with diabetes to improve health outcomes in low- and middle-income countries.
  • Diabetes Investment Accelerator (DIA) Program that explores, implements, and scales innovative financing mechanisms to address the growing burden of diabetes and related NCDs in low- and middle-income countries, including portfolio companies such as Last Mile Care and the Indigenous Diabetes Outcomes Fund.
  • Partner2Partner Academy Capacity-building platform fostering collaboration, learning, and innovation among WDF partners through south-to-south knowledge sharing, networking, and clinical and organisational capacity building for diabetes prevention and care.
  • WDF Fundraising Programme Donor programme enabling individuals and organizations to fund specific diabetes prevention and care projects, including pilot projects and later phases of successful completed projects, via the Foundation's official donation platform.

Quantifiable outcome

  • Contributing to SDG 3.4: reduce by one-third premature mortality from NCDs through prevention and treatment
  • +1 more outcomes

Companies that use World Diabetes Foundation

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles3 records

World Diabetes Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

World Diabetes Foundation partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • Karnataka Health Promotion Trust (KHPT)coreImplementation/ SI/ Consulting Partner · 1 January 2026KHPT leads WDF's 2026 fundraiser 'Beyond Clinics' in Bengaluru, India. The 18-month project aims to improve diabetes and hypertension prevention and care for marginalized adults in urban and peri-urban communities, working with the Greater Bengaluru Authority and Department of Health.
  • UMID Сharity Union of Persons with Disabilities and People with Diabetes Mellitus in UzbekistancoreImplementation/ SI/ Consulting Partner · 1 January 2025UMID Charity union is implementing WDF's 2025 fundraiser project 'Improving diabetes control and quality of life for children in Uzbekistan'. The project runs from January 2025 to March 2026, targeting children with type 1 diabetes in rural areas through summer health camps, school staff training, and parent support groups.
  • Last Mile CarecoreStrategic or Co-development PartnerHealth start-up in WDF's Diabetes Investment Accelerator portfolio committed to transforming healthcare access for industrial workers in India through one-stop-shop physical and digital centers near workplaces.
  • Indigenous Diabetes Outcomes FundcoreStrategic or Co-development PartnerInitiative supported by WDF's Diabetes Investment Accelerator to establish an Indigenous-led outcomes financing model for type 2 diabetes prevention and management in Canadian Indigenous communities.
  • World Health Organization (WHO)coreStrategic or Co-development PartnerWDF works with WHO on NCD prevention and control, including UN High-Level Meetings on NCDs and the Global Diabetes Compact. Dr Bente Mikkelsen, a former WHO Director for NCDs, serves on WDF's Board.
  • International Diabetes Federation (IDF)coreStrategic or Co-development PartnerWDF leverages IDF's KIDS modules 'Children and Diabetes at School' for training programs. Dr Kaushik Ramaiya, WDF board member, serves as Vice President of IDF.
  • Ministry of Health of the Republic of UzbekistancoreStrategic or Co-development PartnerGovernment partner for the 2025 fundraiser project on type 1 diabetes in children, collaborating on healthcare system improvements.
  • Greater Bengaluru AuthoritycoreStrategic or Co-development PartnerGovernment partner for the 2026 'Beyond Clinics' fundraiser, working on community-based diabetes and hypertension care for marginalized urban populations.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

World Diabetes Foundation competitors and assessment

Company assessment

Broad incumbents

  • Children's Investment Fund Foundation (CIFF): Large philanthropic foundation funding child health, NCDs, and climate. Comparable as a LMIC-focused grantmaker with NCD portfolio and outcomes-based financing expertise overlapping with WDF's Diabetes Investment Accelerator.
  • Bloomberg Philanthropies: Major philanthropic vehicle funding global health initiatives including NCD prevention and public health data. Comparable in deploying large-scale resources against NCDs and population health, particularly through advocacy and policy channels.
  • The Leona M. and Harry B. Helmsley Charitable Trust: Major US-based philanthropic foundation with a significant diabetes program and global health investments. Comparable as a large-scale grantmaker addressing diabetes in low-resource settings, though with broader geographic and disease focus.
  • Novo Nordisk Foundation: Large Danish philanthropic foundation with a major focus on diabetes, NCDs, and global health. Highly comparable given overlapping Danish origins, shared board members with WDF, and parallel mission in diabetes prevention and care in LMICs.
  • Wellcome Trust: Large UK-based global health foundation funding NCD research, infectious disease, and health system strengthening in LMICs. Comparable grantmaking scale and mission alignment with SDG 3.4 priorities.
  • Bill & Melinda Gates Foundation: Largest global health foundation, increasingly active in NCDs alongside its core infectious disease portfolio. Comparable in scale, LMIC focus, and convening power; sets the funding benchmark for diabetes/NCD advocacy organizations.

Emerging players

  • Resolve to Save Lives: Global health organization focused on cardiovascular disease and NCD prevention in LMICs, with strong WHO alignment. Comparable as an NCD-focused funder/implementer, particularly given WHO policy linkages similar to WDF.

Direct peers

  • Clinton Health Access Initiative (CHAI): Global health organization implementing health system strengthening and access programs in LMICs. Comparable operational model — partnership-driven, country-led implementation focused on expanding access to care for NCDs and other conditions.
  • PATH: Global health nonprofit working across NCDs, digital health, and health system strengthening in LMICs. Highly comparable as a mission-driven organization operating diabetes/NCD programs and digital health platforms in similar geographies.
  • International Diabetes Federation: Umbrella global diabetes organization with overlapping leadership and KIDS module adoption by WDF. Direct peer in mission and constituency, though IDF operates as a federation of member associations rather than a grantmaker.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

World Diabetes Foundation social profiles

Digital presence

World Diabetes Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

World Diabetes Foundation leadership team

Management profile

Number of profiles

Profiles6 records

World Diabetes Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

World Diabetes Foundation M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about World Diabetes Foundation

What does World Diabetes Foundation do?

World Diabetes Foundation (WDF) is an independent Danish charitable foundation that funds and supports projects for the prevention and care of diabetes and related non-communicable diseases (NCDs) in low- and middle-income countries. The Foundation provides grants to implementing partners such as NGOs, healthcare systems, and government bodies, and operates supporting platforms including the Diabetes Compass digital tool, the Diabetes Investment Accelerator (DIA), the Global Diabetes Walk awareness campaign, and the Partner2Partner Academy for capacity building.

Is World Diabetes Foundation a public or private company?

World Diabetes Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was World Diabetes Foundation founded?

World Diabetes Foundation was founded in 2002. It employs 11 to 50 people.

Where is World Diabetes Foundation based?

World Diabetes Foundation is headquartered in Bagsværd, Denmark, in the Europe region.

How does World Diabetes Foundation make money?

Three revenue lines are on record. Donations and Fundraising is the primary driver. The others are foundation Endowment and grants to Partners.

Who are World Diabetes Foundation's main competitors?

Broad incumbents on record are Children's Investment Fund Foundation (CIFF), Bloomberg Philanthropies, The Leona M. and Harry B. Helmsley Charitable Trust, Novo Nordisk Foundation, Wellcome Trust and Bill & Melinda Gates Foundation. Resolve to Save Lives is listed as an emerging player. Direct peers are Clinton Health Access Initiative (CHAI), PATH and International Diabetes Federation.

Does World Diabetes Foundation have an API?

No public API is recorded for World Diabetes Foundation.

What industry is World Diabetes Foundation in?

World Diabetes Foundation's product category is Global Health Foundation / Nonprofit Diabetes Funding. Its primary akta.pro industry code is HLAJAMAC, Public Health Financing, Budgeting & Grants Management, with a secondary code of BPAGAKAH, International Grantmaking & Development Foundations. Its NAICS code is 813211 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireFour finalists unveiled for the 2026 Africa Prize for Engineering InnovationFour finalists for the 2026 Africa Prize for Engineering Innovation were unveiled, including a urine-to-fertiliser system, mobile dialysis, AI ECG, and medical monitoring. They will pitch at the final on 28 October in Johannesburg, with one winner receiving £50,000 and three others £10,000 each.Digital Health NewsiKure Raises $1.8 Mn Pre-Series A to Expand Technology-Enabled Primary Healthcare Across IndiaiKure Techsoft raised $1.8M in pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The Kolkata-based startup will use the funds to expand its healthcare hubs, clinics, pharmacies, and diagnostic capabilities across India. It plans to add AI-enabled clinical decision support tools and remote patient monitoring.Medical BuyerKure raises USD 1.8M from four global healthcare leadersiKure Techsoft raised USD 1.8M in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The capital will expand its healthcare hubs, clinics, and diagnostic capacity, and fund AI-enabled clinical decision support. The company plans to scale its technology-enabled primary care model across India.The Times of IndiaiKure bags USD 1.8 Million from global investors to expand primary healthcare in IndiaiKure Techsoft raised USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The capital will expand its frontline health workforce and digital platform WHIMS across underserved regions in India. The company aims to strengthen continuous care for diabetes, hypertension, and maternal health.The Times of IndiaiKure bags USD 1.8 Million from global investors to expand primary healthcare in IndiaiKure Techsoft raised USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and others. The capital will expand its frontline health workforce and digital platform across underserved regions in India. The company aims to strengthen continuous care beyond the first consultation.BusinessLineGlobal Healthcare Leaders Back iKure’s USD 1.8 Million Pre-Series A to Scale Technology-Enabled Primary Healthcare Across IndiaiKure Techsoft secured USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The company operates across 11 Indian states, reaching 7,900 villages and 36 million+ people. The funding will expand its healthcare infrastructure and AI-enabled clinical decision support.Business StandardGlobal Healthcare Leaders Back iKure's USD 1.8 Million Pre-Series A to Scale Technology-Enabled Primary Healthcare Across IndiaiKure Techsoft secured USD 1.8 million in pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The company operates in 11 Indian states, reaching 7,900 villages and 36 million+ people. The funding will expand its healthcare infrastructure and AI-enabled clinical decision support.The TribuneGlobal Healthcare Leaders Back iKure's USD 1.8 Million Pre-Series A to Scale Technology-Enabled Primary Healthcare Across IndiaiKure Techsoft raised USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The company operates across 11 Indian states, reaching 7,900 villages and 36 million+ people with over 4.5 million patient interactions. The funding will expand its healthcare infrastructure and AI-enabled clinical decision support.The HinduGlobal Healthcare Leaders Back iKure’s USD 1.8 Million Pre-Series A to Scale Technology-Enabled Primary Healthcare Across IndiaiKure Techsoft secured USD 1.8 million in Pre-Series A funding from Philips Foundation, World Diabetes Foundation, Bayer Foundation, and Prourgn LLC. The company operates across 11 Indian states, reaching 7,900 villages and 36 million+ people. The funding will expand its healthcare infrastructure and AI-enabled clinical decision support.